Clinical Trials Directory

Trials / Completed

CompletedNCT05959915

ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

To compare the number of patients with AF recurrence detected in a 24-h Holter monitoring with a 5-day record.

Conditions

Interventions

TypeNameDescription
DEVICEdevice e-patch ImplantationThe ePatch device (Phillips) was used. This device is attached to the sternum, using a specific dressing adapted for the device itself. Manufacturer's recommendations for skin preparation and placement will be followed. The device will remain in place for 4-5 days, at which time the patient will be readmitted for data extraction and reading. The team of research nurses will analyze the data through the ePatch platform and later, the electrophysiologists will review the results and make a diagnosis.

Timeline

Start date
2023-07-01
Primary completion
2024-07-01
Completion
2025-06-01
First posted
2023-07-25
Last updated
2025-07-10

Locations

1 site across 1 country: Spain

Regulatory

Source: ClinicalTrials.gov record NCT05959915. Inclusion in this directory is not an endorsement.

ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation (NCT05959915) · Clinical Trials Directory